title: A case of reversible cardiomyopathy associated with sorafenib in advanced hepatocellular carcinoma.
authors.forename: Hyekyong
authors.initials: H
authors.lastname: Park
authors.forename: Seung-Hee
authors.initials: SH
authors.lastname: Han
authors.forename: Hyojin
authors.initials: H
authors.lastname: Kang
authors.forename: Kyungil
authors.initials: K
authors.lastname: Park
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D009202:Cardiomyopathies / Q000139:chemically induced*; D017023:Coronary Angiography; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D009536:Niacinamide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib